Top

BMC Pediatrics

Published in:

Open Access 01-12-2021 | Obesity | Research article

Lipid profile of Mexican children with Down syndrome

Authors: Silvestre Garcia-de la Puente, Karla A. Flores-Arizmendi, María J. Delgado-Montemayor, Tania T. Vargas-Robledo

Published in: BMC Pediatrics | Issue 1/2021

Abstract

Introduction

Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood. This study was designed to describe the lipid concentrations and the frequency of dyslipidemias in children with DS.

Materials and methods

The sample included 386 patients, 52.4% male. The study was carried out on children with DS, aged 2–18 years old, who were patients at the Mexican National Institute of Pediatrics between May 2016 and June 2017. Their height and weight were recorded, and their serum cholesterol, HDL cholesterol, and triglyceride levels were determined.

Results

Of the total patients included, 57.5% had some type of dyslipidemia, 32.6% isolated and 24.9% combined. The most common alteration, considering both isolated and combined dyslipidemias, was low HDL, in 45.9%, followed by hypertriglyceridemia, in 26.2%. Among those with combined dyslipidemia, high TG with low HDL-c was the most common, in 17.9%. A significant association was found between dyslipidemia and obesity, as well as between dyslipidemia and central obesity. The percentiles of lipid values are reported.

Conclusion

The presence of an unfavorable lipid profile is common in pediatric patients with Down syndrome, especially low HDL cholesterol and high triglycerides.

Available only for authorised users

Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–16. https://doi.org/10.1002/bdra.20735.CrossRefPubMed

Zamorano AV, Guzman MT, Aspillaga MH, et al. Concentraciones de lipidos sericos en ninos con sindrome de Down. [Concentrations of serum lipids in Children with Down syndrome.]. Arch Biol Med Exp (Santiago). 1991;24(1):49–55.

De la Piedra MJ, Alberti G, Cerda J, et al. High frequency of dyslipidemia in children and adolescents with Down syndrome. Rev Chil Pediatr. 2017;88(5):595–601.CrossRef

Buonuomo PS, Bartuli A, Mastrogiorgio G, et al. Lipid profiles in a large cohort of Italian children with Down syndrome. Eur J Med Genet. 2016;59(8):392–5. https://doi.org/10.1016/j.ejmg.2016.06.005.CrossRefPubMed

Adelekan T, Magge S, Shults J, Stallings V, Stettler N. Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics. 2012;129(6):e1382–7. https://doi.org/10.1542/peds.2011-1262.CrossRefPubMedPubMedCentral

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRef

Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagné C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem. 2004;37(9):785–90. https://doi.org/10.1016/j.clinbiochem.2004.03.008.CrossRefPubMed

Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240–3. https://doi.org/10.1136/bmj.320.7244.1240.CrossRefPubMedPubMedCentral

Cole TJ, Flegal KM, Nicholls D, Jackson AA. Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ. 2007;335(7612):194. https://doi.org/10.1136/bmj.39238.399444.55.CrossRefPubMedPubMedCentral

10.

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213–56. https://doi.org/10.1542/peds.2009-2107C.CrossRef

11.

Bocconi L, Nava S, Fogliani R, Nicolini U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol. 1997; m J Obstet Gynecol. 1997 Mar;176(3):540–3. https://doi.org/10.1016/s0002-9378(97)70544-1.CrossRefPubMed

12.

Bibiloni MDM, Salas R, Novelo HI, Villarreal JZ, Sureda A, Tur JA. Serum lipid levels and dyslipidaemia prevalence among 2-10 year-old northern Mexican children. PLoS One. 2015;10(3):1–14. https://doi.org/10.1371/journal.pone.0119877.CrossRef

13.

Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591–600. https://doi.org/10.1001/jama.2012.9136.CrossRefPubMed

14.

Laris EM, Arteaga LA, Cuevas MA, et al. El colesterol HDL: ¿un nuevo objetivo terapéutico en el manejo de las dislipidemias y la ateroesclerosis?. [HDL cholesterol: A new therapeutic objective in the management of dyslipidemias and atherosclerosis?]. Rev Méd Chile. 2005;133:823–32. https://doi.org/10.4067/S0034-98872005000700011.CrossRef

15.

Rader DJ, Rosas S. Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation. Med Clin North Am. 2000;84(1):43–61. https://doi.org/10.1016/s0025-7125(05)70206-6.CrossRefPubMed

16.

ENSANUT 2018. Encuesta Nacional de Salud y Nutrición [National Survey of Health and Nutrition] Ensanut 2018.

17.

Arjona-Villicaña RD, Herrera-Sánchez LF, Sumárraga-Ugalde C, Ma A-G. Asociación entre el índice de masa corporal y el perfil de lípidos en niños y adolescentes mexicanos con obesidad: un análisis retrospectivo. [Association between body mass index and lipid profile in Mexican children and adolescents with obesity: A retrospective analysis.]. Boll Med Hosp Infant Mex. 2014;71(2):88–94.

18.

Kavey REW. Combined dyslipidemia in childhood. J Clin lipido. 2015;9(5):S41–56. https://doi.org/10.1016/j.jacl.2015.06.008.CrossRef

19.

Hill DA, Gridley G, Cnattingius S, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med. 2003;163(6):705–11. https://doi.org/10.1001/archinte.163.6.705.CrossRefPubMed

20.

Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol. 2005;47(3):171–6. https://doi.org/10.1017/s0012162205000319.CrossRefPubMed

21.

Newman WP 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa heart study. N Engl J Med. 1986;314(3):138–44. https://doi.org/10.1056/NEJM198601163140302.CrossRefPubMed

Title: Lipid profile of Mexican children with Down syndrome
Authors: Silvestre Garcia-de la Puente
Karla A. Flores-Arizmendi
María J. Delgado-Montemayor
Tania T. Vargas-Robledo
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Obesity
Obesity
Dyslipidemia
Trisomy 21
Published in: BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-021-02542-1

At a glance: The STEP trials

Springer Medicine

Lipid profile of Mexican children with Down syndrome

Abstract

Introduction

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Langerhans cell histiocytosis misdiagnosed as cow protein allergy: a case report

Barriers, facilitators and solutions for active inclusive play for children with a physical disability in the Netherlands: a qualitative study

Can large doses of glucocorticoids lead to Perthes? a case report and review of the literature

Preliminary evidence for an influence of exposure to polycyclic aromatic hydrocarbons on the composition of the gut microbiota and neurodevelopment in three-year-old healthy children

Novel type of references for weight aligned for onset of puberty – using the QEPS growth model

The role of tobacco smoking and illicit drug use in adolescent acute alcohol intoxication